• Genoa in the News

Genoa Healthcare’s handling of the pandemic featured in Chain Drug Review

Jun 8th, 2021

Increase in Mental Illness & Substance Abuse during Pandemic

As rates of mental illness and substance use disorder rose during the COVID-19 pandemic, Genoa Healthcare stepped up to improve access to care and promote better health care outcomes. Genoa’s efforts to meet the needs of the behavioral health community during the pandemic were featured recently in Chain Drug Review magazine. You can read the full article here or view it in the Chain Drug Review April issue.

The article highlights the growing need for behavioral health services and access to care and explains how Genoa pharmacies adapted to meet the changing needs of clinic partners and consumers. Pharmacies increased delivery and curbside pickup services, made proactive check-in calls and integrated with telehealth providers to ensure consumers were able to stay on their medication plans.

In addition, Genoa pharmacies have partnered with states and counties to administer COVID-19 vaccines in their local communities, ensuring that chronically underserved individuals had access to immunization clinics.

Read the full article for more information.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
4 things to know about Spravato® (Intranasal esketamine)

On January 21, 2025, the FDA announced the approval of Spravato® nasal spray as a monotherapy treatment for treatment-resistant depression (TRD), making this medication the first and only monotherapy option...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa’s 2024 Art Celebration: Celebrating the healing power of creativity

“I’ve always expressed myself through my art and learned to use my creativity to inspire others”, says Genoa Healthcare 2024 Art Celebration participant Shanelle G. Genoa’s annual Art Celebration invites...

Partner with Genoa
  • Behavioral Health
  • Clinical Insights
  • Treatment
Esketamine: Latest research offers new hope for adolescents with treatment-resistant depression

Adolescents with treatment-resistant depression (TRD) often struggle with a lack of effective treatment options. While ketamine has been shown to help improve outcomes for adults living with major depressive disorder...

  • Behavioral Health
  • Clinical Insights
  • Partnering with Genoa
CMS reporting now required: 4 ways Genoa can help

By Reena Neumann, PharmD, MBA Since January 1, 2024, the Centers for Medicare & Medicaid Services (CMS) has required that clinics provide outcomes data reporting to secure federal funding through...